1.9300.52% ( -0.010 )
Closed: Nov 3, 15:59:52 (EDT)Forecast & Rating3 analysts currently cover Aytu BioPharma, of which 3 give a positive rating. The average price target is $9.67, about 400.9% upside from the current price of $1.93. Coverage is limited, so the data is for reference only. Data as of Oct 12, 2026; this does not constitute investment advice.
Oct 12, 2026Price forecast
$9.67397.00%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 2
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
Target price forecast
Forecast dateNov 2, 2026
Forecast met0.0%
Stock price$1.95
Avg. target$9.3
High target$13
Low target$7
- Avg. target
- $9.3
- High target
- $13
- Low target
- $7
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.
